After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.
In today’s complex, highly competitive dealmaking environment, it’s critical to deploy state-of-the-art technology for M&A and other high-value strategic pursuits.
Preparing for economic downturn, investors turn to private equity. Mergers & Acquisitions profiles the top U.S. PE firms, including Gentstar. Novartis completes spinoff of Alcon, plus deals from Macquarie, Stanadyne.
Novartis buys Endocyte, snapping up a potential blockbuster therapy for prostate cancer. FedEx buys Australian logistics company. Now that cannabis is legal in Canada, what should U.S. private equity firms do?